Sep 3, 2008 By:
Robert E. Batte, Innovative Strategic Communications
|
A strange silence prevades the exhibition floors of healthcare conventions. Is the current regulatory environment preventing the exchange of scientific information? And what can you, as an exhibitor, do about it?

Sep 3, 2008 By:
Marylyn Donahue, Special Projects Editor
|
What effect is the new regulatory environment having on medical meetings, and what does it mean for their future health?

Sep 3, 2008 By:
Marylyn Donahue, Special Projects Editor
|
Enticing, engaging, and a magnet for collecting data, interactive exhibits are perfectly suited for pharmaceutical marketing. And while they will never take the place of a sales rep, the purpose is to keep everyone on message and to educate in the process

Sep 3, 2008 By:
Judy Benaroche Johnson, Rx Worldwide Meetings, Inc.
|
Designed to rein in the relationship between sales reps and doctors, PhRMA's new, revised code may end up having an adverse effect on clinical trials

Sep 3, 2008 By:
Scott Stoogenke, Informed Medical Communications
|
Be it a dinner meeting, lunch-and-learn, or teleconference, successful marketing of a brand depends on maximizing peer interaction among professionals

Sep 3, 2008 By:
Elio Evangelista, Cutting Edge Information
|
Physcians are balking at attending meetings—a result of one of many regulatory challenges industry meetings planners are besieged with on a weekly basis. A new report reveals what pharmaceutical companies are doing about it.

Sep 1, 2008 By:
Charlene Prounis
|
As oncology grows, its advertising is growing up—leaving behind the mechanistic images and scientific themes of past campaigns

Sep 1, 2008 By:
Bill Trombetta
|
Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)

Sep 1, 2008 By:
Joanna Breitstein
|
The industry is a-changing. Here are eight seminal events that describe how.
